-+ 0.00%
-+ 0.00%
-+ 0.00%
Corsera Health named to Endpoints 11 list of top biopharma startups for 2026
Share
Listen to the news
Corsera Health named to Endpoints 11 list of top biopharma startups for 2026
  • Forbion portfolio company Corsera Health was named to Endpoints News’ 2026 “Endpoints 11” list of top private biopharma startups.
  • The clinical-stage cardiovascular company is advancing its first preventive RNAi medicine through Phase 1 development.
  • Corsera highlighted its Klotho AI platform focused on early prediction of lifetime cardiovascular disease risk.
  • The recognition was marked at an awards gala in Boston on Sept. 24, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Forbion Capital Partners Management Services BV published the original content used to generate this news brief on September 25, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending